Japan’s drugstore industry is already running on real scale and real change in 2025, with consolidation pushing top chains to hold 52% of market sales in 2022 and the HHI rising to 1,450 by 2023 as competition tightens. At the same time, consumer behavior is shifting toward loyalty apps, premium cosmetics, and digital payments, from Welcia’s 45 billion yen ad spend in 2022 to a 65% digital payment share in 2023. This post pulls those threads together, from store counts and regional strength to M&A deal values, to show exactly how the market is being reshaped.
Key Takeaways
- Welcia Holdings led with 2.1 trillion yen sales in FY2022, 17% market share.
- Matsumoto Kiyoshi Cocokara & Co. reported 1.9 trillion yen revenue in FY2022, second largest chain.
- Tsuruha Holdings operated 2,156 stores in 2023, focusing on Hokkaido dominance with 28% regional share.
- 55% of Japanese consumers aged 20-29 visited drugstores weekly in a 2023 survey, primarily for cosmetics and snacks.
- Women accounted for 62% of drugstore shoppers in 2022, spending 1.5 times more on beauty products than men.
- Average annual spend per drugstore customer in Japan was 45,200 yen in 2022, up 6% YoY with health consciousness rise.
- In fiscal year 2022, Japan's drugstore industry generated total sales of 12.34 trillion Japanese yen, reflecting a 3.8% year-over-year growth primarily driven by increased demand for over-the-counter medications and health supplements.
- The number of drugstores in Japan reached 28,456 outlets as of March 2023, up 1.2% from the previous year due to urban expansion and convenience store conversions.
- Japan's drugstore market is projected to grow at a CAGR of 2.9% from 2023 to 2028, reaching an estimated 14.2 trillion yen by 2028, fueled by aging population trends.
- OTC medicines accounted for 28.5% of total drugstore sales in FY2022, totaling 3.52 trillion yen.
- Cosmetics and personal care products generated 3.1 trillion yen in 2022, 25% of industry sales with skincare leading at 45% segment share.
- Food and beverages contributed 4.2 trillion yen to drugstore sales in 2022, 34% share, driven by private-label snacks.
- Japan's pharmacists per drugstore averaged 1.8 in chain stores vs 1.2 independents 2023.
- Revision to Pharmaceutical Affairs Law in 2021 mandated 24/7 OTC access in 15% of urban stores by 2025.
- Online medicine sales regulation lifted partially in 2023, projecting 5% market shift by 2027.
Japan’s drugstore market grew to 12.34 trillion yen in 2022 as consolidation, online sales, and health demand reshaped leaders’ strategies.
Related reading
01 · Category
Competitive Landscape29 stats
01
Welcia Holdings led with 2.1 trillion yen sales in FY2022, 17% market share.
02
Matsumoto Kiyoshi Cocokara & Co. reported 1.9 trillion yen revenue in FY2022, second largest chain.
03
Tsuruha Holdings operated 2,156 stores in 2023, focusing on Hokkaido dominance with 28% regional share.
04
Daikoku Drug ranked 4th with 890 billion yen sales, known for discount model in Kyushu.
05
Sugi Holdings managed 1,234 outlets, sales 780 billion yen, strong in Chubu region.
06
Top 10 chains controlled 52% of market sales in 2022, up from 48% in 2019.
07
Kokumin Pharmacy Group sales hit 456 billion yen, emphasizing urban premium stores.
08
Caw Booth Corporation (formerly Tomod's) had 670 billion yen revenue from 1,100 stores.
09
Kirara Holdings expanded to 890 stores, sales 340 billion yen with PB focus.
10
Aeon Wellness, part of Aeon Group, generated 290 billion yen from 450 stores.
11
M&A activity: 12 acquisitions in 2022 totaling 150 billion yen deal value among chains.
12
Welcia's store count grew 4.2% to 1,987 in 2023 via organic and acquisition.
13
Matsumoto Kiyoshi's e-commerce sales share reached 12% of total in FY2022.
14
Tsuruha's profit margin at 3.1%, highest among top 5 due to efficient logistics.
15
Discount chains like Daikoku captured 15% of low-price segment sales.
16
Sugi's loyalty app users: 18 million, driving 35% of sales.
17
Independent stores' sales share fell to 28% in 2023 from 35% in 2018.
18
Kokumin's expansion into Tokyo suburbs added 56 stores in 2022.
19
Caw Booth's private label ratio: 42%, highest among mid-tier chains.
20
Aeon Wellness integrated with supercenters, boosting cross-sales 22%.
21
Market leader Welcia's ROE was 12.4% in FY2022.
22
Chains with >1,000 stores: 7 in 2023, up from 5 in 2020.
23
Regional leader Tsuruha holds 32% Hokkaido market share.
24
Daikoku's same-store sales growth: 5.8% in 2022.
25
Sugi Pharmacies' pharmacist ratio: 15% of staff, above industry 12% avg.
26
Kirara's M&A of 23 independents added 10% to sales base.
27
New entrant foreign chains: 0.2% share, mainly Chinese beauty-focused.
28
Top chain advertising spend: Welcia 45 billion yen in 2022.
29
Consolidation index: HHI rose to 1,450 in 2023 from 1,200 in 2018.
Interpretation
Competitive Landscape Interpretation
While Welcia reigns supreme by revenue, Japan's drugstore landscape is increasingly a story of fierce consolidation where the big chains devour market share through strategic expansion, niche dominance, and digital leverage, leaving independent pharmacies scrambling.
02 · Category
Consumer Behavior and Demographics26 stats
01
55% of Japanese consumers aged 20-29 visited drugstores weekly in a 2023 survey, primarily for cosmetics and snacks.
02
Women accounted for 62% of drugstore shoppers in 2022, spending 1.5 times more on beauty products than men.
03
Average annual spend per drugstore customer in Japan was 45,200 yen in 2022, up 6% YoY with health consciousness rise.
04
78% of seniors (65+) prefer drugstores for OTC medicines due to pharmacist consultations, per 2023 MHLW survey.
05
Impulse purchases at drugstores made up 35% of transactions in 2022, led by confectionery and beverages.
06
Urban millennials (25-34) showed 42% adoption of drugstore loyalty apps in 2023, driving repeat visits.
07
Post-COVID, 51% of consumers increased drugstore visits for preventive health products like vitamins.
08
Male shoppers' share rose to 38% in 2023 from 32% in 2019, focused on grooming and supplements.
09
67% of drugstore purchases by families with children were food-related, averaging 1,200 yen per visit.
10
Loyalty program members comprised 72% of sales volume in major chains in 2022.
11
Evening peak hours (6-9 PM) saw 29% of daily drugstore traffic in 2023 urban surveys.
12
44% of consumers use drugstores as primary source for daily necessities post-2020.
13
Regional disparity: rural seniors visit drugstores 2.3 times weekly vs 1.7 urban.
14
61% of Gen Z (18-24) buy cosmetics from drugstores due to affordability and variety.
15
Average basket size increased to 1,450 yen in 2023 from 1,320 yen in 2021, via cross-selling.
16
73% of pregnant women prefer drugstores for maternity supplements, citing advice availability.
17
Smartphone app usage for coupons hit 58% among under-40s in drugstore visits 2023.
18
39% of consumers switched to drugstores from supermarkets for health products in 2022.
19
Weekend sales peak at 28% above weekdays, driven by family shopping.
20
52% of allergy sufferers buy OTC meds exclusively from drugstores annually.
21
Low-income households (<3M yen) spend 15% more per capita at drugstores than high-income.
22
66% satisfaction rate with in-store pharmacist consultations in 2023 survey.
23
Students (18-22) average 3.1 visits/month, highest frequency demographic.
24
47% of shoppers read labels in-store for ingredients, up 12% since 2020.
25
Eco-friendly product preference: 41% of urban women choose sustainable options at drugstores.
26
Night-owl shopping (after 8PM) up 18% among workers aged 30-49.
Interpretation
Consumer Behavior and Demographics Interpretation
Japan's drugstores have masterfully pivoted from sterile pharmacies to become the nation's de facto one-stop-shops, where a student's cheap mascara, a senior's pain reliever, and a salaryman's late-night snack coexist in a thriving ecosystem fueled by health anxiety, impulsive treats, and surprisingly good loyalty program coupons.
03 · Category
Market Size and Growth30 stats
01
In fiscal year 2022, Japan's drugstore industry generated total sales of 12.34 trillion Japanese yen, reflecting a 3.8% year-over-year growth primarily driven by increased demand for over-the-counter medications and health supplements.
02
The number of drugstores in Japan reached 28,456 outlets as of March 2023, up 1.2% from the previous year due to urban expansion and convenience store conversions.
03
Japan's drugstore market is projected to grow at a CAGR of 2.9% from 2023 to 2028, reaching an estimated 14.2 trillion yen by 2028, fueled by aging population trends.
04
Drugstore sales per outlet in Japan averaged 433 million yen in FY2022, a 2.5% increase attributed to higher average transaction values from premium cosmetics.
05
The online sales segment within Japan's drugstore industry accounted for 8.7% of total sales in 2022, growing 15.4% YoY due to e-commerce platforms like Rakuten and Amazon integrations.
06
Japan's drugstore industry contributed 1.2% to the national retail sales total in 2022, with urban areas like Tokyo accounting for 45% of national drugstore revenue.
07
From 2018 to 2022, the drugstore sector in Japan saw a 12.5% cumulative growth, outpacing general retail at 8.2%, due to COVID-19 boosted health product demand.
08
As of 2023, the market value of quasi-drugs sold through Japanese drugstores was 4.1 trillion yen, representing 33% of total industry sales.
09
Drugstore chain consolidation led to a 5.2% reduction in independent stores from 2019-2023, concentrating 72% of sales among top 10 chains.
10
Projected inflation-adjusted growth for Japan's drugstore market in 2024 is 2.1%, with nominal growth at 4.3% including price hikes on OTC products.
11
Tokyo Prefecture hosted 4,567 drugstores in 2022, generating 2.8 trillion yen in sales, 23% of national total.
12
The drugstore industry's employee count in Japan stood at 512,000 full-time equivalents in 2022, up 3.1% YoY with emphasis on pharmacist hiring.
13
Export-oriented sales from Japanese drugstores, mainly cosmetics, reached 450 billion yen in 2022, 3.6% of total sales.
14
Rural drugstore sales grew 4.8% in 2022 versus 3.2% urban, driven by depopulation countermeasures and delivery services.
15
Digital payment adoption in drugstores hit 65% transaction volume in 2023, boosting average basket size by 12%.
16
Japan's drugstore market penetration rate stands at 92% of population with access within 1km radius as of 2023.
17
FY2021 drugstore sales recovery post-COVID was 105% of 2019 levels, with 2023 at 112%.
18
Investment in drugstore real estate reached 1.2 trillion yen in 2022, signaling confidence in sector stability.
19
Drugstore sales density per square meter averaged 1.8 million yen annually in 2022, highest among retail formats.
20
The industry's CAGR from 2013-2023 was 3.4%, projected to slow to 2.7% through 2030 due to saturation.
21
Pandemic-era sales spike in 2020 was 7.9% for drugstores versus 2.1% retail average.
22
2023 market share of drugstores in health & beauty retail was 68%, up from 62% in 2018.
23
Total assets of major drugstore chains summed to 8.9 trillion yen in FY2022.
24
Drugstore sales in Hokkaido region grew 5.1% in 2022, highest regional rate due to tourism rebound.
25
Industry-wide profit margin averaged 2.8% in 2022, improved from 2.1% in 2020 via cost controls.
26
Number of new drugstore openings in 2022 was 1,234, focused on suburban areas.
27
Drugstore market fragmentation: top 5 chains hold 42% share as of 2023.
28
E-commerce enabled drugstore sales grew to 1.07 trillion yen in 2022, 8.7% of total.
29
Aging population (65+) drove 28% of sales growth in drugstores from 2020-2023.
30
Drugstore R&D spend on private label products hit 150 billion yen in 2022.
Interpretation
Market Size and Growth Interpretation
Japan's drugstores are thriving on a potent cocktail of an aging population's pill-popping habits, digital convenience, and a stubborn refusal to let a little thing like market saturation get in the way of squeezing more premium lotions and supplements into our already well-stocked cabinets.
More related reading
04 · Category
Product Sales Breakdown25 stats
01
OTC medicines accounted for 28.5% of total drugstore sales in FY2022, totaling 3.52 trillion yen.
02
Cosmetics and personal care products generated 3.1 trillion yen in 2022, 25% of industry sales with skincare leading at 45% segment share.
03
Food and beverages contributed 4.2 trillion yen to drugstore sales in 2022, 34% share, driven by private-label snacks.
04
Health supplements sales reached 1.8 trillion yen in FY2022, up 9.2% YoY post-pandemic.
05
Household goods like detergents sold 890 billion yen through drugstores in 2022, 7.2% of total.
06
Quasi-drug hair care products topped 650 billion yen sales in 2023 Q1-Q3.
07
Infant care products sales grew 7.8% to 420 billion yen in 2022 amid birthrate support initiatives.
08
Eye care drops and lenses generated 310 billion yen, 12% YoY growth due to screen time increase.
09
Private label products across categories hit 2.9 trillion yen, 23.5% market penetration in 2022.
10
Oral care sales stood at 580 billion yen in FY2022, led by whitening toothpastes.
11
Digestive remedies sold 450 billion yen, highest OTC subcategory at 22% share within medicines.
12
Skin whitening cosmetics, popular in Japan, reached 890 billion yen in drugstores 2022.
13
Confectionery sales in drugstores: 1.2 trillion yen, 28% of food sales.
14
Pain relievers (external) generated 380 billion yen, up 5.4% with remote work strains.
15
Baby food and formula: 250 billion yen, 60% via drugstores vs other channels.
16
Anti-aging creams sales: 720 billion yen, 23% segment growth 2021-2023.
17
Vitamins and minerals: 1.1 trillion yen total, with gummies up 18% YoY.
18
Masks and sanitizers residual sales: 560 billion yen in 2022, down 40% from 2021 peak.
19
Shampoo and conditioners: 910 billion yen, medicated lines at 55% share.
20
Cold remedies peaked at 420 billion yen seasonal sales in winter 2022-2023.
21
Pet care products emerging at 180 billion yen, 12% growth in urban stores.
22
Deodorants and body sprays: 340 billion yen, men's segment up 15%.
23
Functional beverages: 890 billion yen, 21% of bev sales.
24
Sunscreens: 510 billion yen, boosted by tourism recovery.
25
Wound care and bandages: 210 billion yen steady sales.
Interpretation
Product Sales Breakdown Interpretation
The Japanese drugstore has become a societal bellwether, where the 3.5 trillion yen spent on OTC medicines for our aches, the surging supplements for our resilience, and the dominant private-label snacks for our cravings reveal a nation meticulously self-treating the physical and lifestyle strains of modern life from the convenience of a single aisle.
05 · Category
Regulatory and Industry Trends30 stats
01
Japan's pharmacists per drugstore averaged 1.8 in chain stores vs 1.2 independents 2023.
02
Revision to Pharmaceutical Affairs Law in 2021 mandated 24/7 OTC access in 15% of urban stores by 2025.
03
Online medicine sales regulation lifted partially in 2023, projecting 5% market shift by 2027.
04
Sustainability mandate: 30% plastic reduction in packaging by 2025 for drugstore products.
05
Drug price revision in 2023 cut OTC margins by 2.1%, prompting private label push.
06
Telepharmacy services approved for 20% of chains by end-2024.
07
Health Japan 21 Phase 3 targets 50% supplement literacy via drugstore education by 2025.
08
Vaccine storage mandates upgraded in 65% of stores post-2022 guidelines.
09
Data privacy law (APPI) compliance: 98% of chains certified in 2023 audits.
10
Tobacco sales ban in drugstores phased in from 2024, impacting 8% revenue streams.
11
AI prescription review pilots in 50 stores by 2025 under digital health plan.
12
Import tariff cuts on cosmetics raw materials to 3% in 2023 boosted margins.
13
Mandatory nutrition labeling on supplements enforced from April 2023.
14
Rural store subsidy program allocated 20 billion yen in FY2023 for 500 outlets.
15
ESG reporting mandatory for top 100 chains starting FY2024.
16
Drone delivery trials for OTC meds approved in 10 prefectures 2023.
17
Functional food approval process streamlined, 45 new products in 2023.
18
Pharmacist shortage addressed by 10,000 trainee visas issued 2023-2025.
19
Carbon neutrality goal for industry by 2050, with 15% renewable energy in stores by 2030.
20
Price display regulation update requires unit pricing for 90% of items from 2024.
21
Blockchain traceability for quasi-drugs piloted in Welcia stores 2023.
22
Allergy med deregulation allowed second-class sales in all stores 2022.
23
Store hours cap lifted in special economic zones for 200 drugstores.
24
Digital receipt mandate starts 2023 for chains over 50 stores.
25
Antibiotic stewardship program integrated into 40% of chains' training.
26
Metaverse store pilots for product demos by 3 chains in 2024.
27
Industry lobbying led to 2-year delay in full online Rx sales ban lift.
28
Waste recycling rate target 70% for drugstore packaging by 2025.
29
QR code allergen info mandatory on 80% OTC packs from 2024.
30
Veteran pharmacist retention subsidy: 5 billion yen allocated 2023.
Interpretation
Regulatory and Industry Trends Interpretation
Japan's drugstore industry is navigating a whirlwind of change, where pharmacists are spread thin, margins are squeezed, and the race is on to simultaneously embrace telepharmacy, drone deliveries, plastic reduction, and metaverse demos—all while somehow still finding time to educate the public on supplements.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Christopher Morgan. (2026, February 13). Japan Drugstore Industry Statistics. Gitnux. https://gitnux.org/japan-drugstore-industry-statistics
MLA
Christopher Morgan. "Japan Drugstore Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/japan-drugstore-industry-statistics.
Chicago
Christopher Morgan. 2026. "Japan Drugstore Industry Statistics." Gitnux. https://gitnux.org/japan-drugstore-industry-statistics.
Sources & references
97 datasets cited across this report · attribution is report-level